Study Finds Flaws in New Treatment For Blood Clots, JAMA Reveals
In recent years, catheter-directed thrombolysis (CDT) has been added to the current standard of anticoagulation therapy in some patients with deep vein thrombosis (DVT). The hope was that CDT would help reduce the high rate of post-thrombotic syndrome (PTS), but now an observational study finds no benefits and some important disadvantages associated with CDT.
Hey, check out all the research scientist jobs. Post your resume today!